Investors

Copyright Nasdaq. Minimum 15 minutes delayed.

Immunovaccine Positive Clinical Data from Its First Combination Immunotherapy Trial with Incyte in Advanced Ovarian Cancer Conference Call

Dec 5, 2017 at 8:00 AM EST